Skip to content

Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs

Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06912776
Enrollment
40
Registered
2025-04-06
Start date
2025-06-20
Completion date
2027-07-01
Last updated
2026-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum

Keywords

Pregnancy, Postpartum, nulliparus

Brief summary

This study aims to create a novel visual education tool that builds on the urgent maternal warning signs identified by The Council on Patient Safety in Women's Health Care. Including effective images will improve the understanding of these grave warning signs/symptoms, improving anatomical accuracy while remaining simplistic for patients of varying levels of health care literacy. The investigative team will be focusing on urgent warning signs pertinent to the postpartum period.

Interventions

OTHERParticipant will view a visual aid picture (appendix A) first

Participant will view a visual aid picture (appendix A) of a post delivery complication first

OTHERParticipant will view a visual aid picture (appendix B) first

Participant will view a visual aid picture (appendix B) of a post delivery complication first

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Postpartum women * Nulliparity * Age \>18 years of age * English speaking patients

Exclusion criteria

* Inability to provide informed written consent * Refusal to participate in all study-related procedures * Patients not fluent in English * Patients with current or history of serious peripartum complications and/or events - such as DVT, PE, peripartum cardiomyopathy, etc. (in which the patient may have received more than standard clinical counseling) * Patient with comorbidities that potentially require anticoagulation i.e. coagulopathies and may be more prone to DVTs * Patients with uncorrected visual or hearing impairment * Healthcare providers (in which patients will have significant background knowledge)

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who recognize deep vein thrombosis,1 DayParticipant will accurately identify the health care issue shown to participants and identified as Picture A and Picture B

Secondary

MeasureTime frameDescription
Number of participants who demonstrate understanding deep vein thrombosis,1 DayParticipants written response of the understanding of deep vein thrombosis.
Number of participants who would report deep vein thrombosis1 DayAfter review of Picture A and Picture B number of participants who report deep vein thrombosis to their care provider or emergency room.

Countries

United States

Contacts

CONTACTPaul C Fitzgerald, RN,BSN,MS
p-fitzgerald2@northwestern.edu3126951064
PRINCIPAL_INVESTIGATORKaitlyn Neumann, MD

Northwestern University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 11, 2026